Analysis: Lethal Injection on Trial, Already on Hold in 12 States; Death Penalty Faces Further Attacks in Courts and Legislatures This Year

Report Read time:
Analysis: Lethal Injection on Trial, Already on Hold in 12 States; Death Penalty Faces Further Attacks in Courts and Legislatures This Year

Since capital punishment was reinstated three decades ago, nearly 900 of more than 1,055 U.S. executions have been carried out by lethal injection. But what was seen as a more humane alternative to the gas chamber, electric chair, firing squad or gallows now faces serious challenges.

The execution in Ohio last May of double-murderer Joseph Clark is a stark example of why America is taking a harder look at lethal injection.

Although Ohio had carried out 20 lethal injections without incident, prison officials encountered serious problems in executing Clark, a long-time intravenous drug user convicted of killing a service station attendant and a convenience store clerk. Reporters who witnessed the execution said Clark, 57, raised his head off the gurney and said repeatedly, "It don't work. It don't work." Prison officials closed the viewing curtain as they struggled to find a vein to inject the deadly chemicals. The procedure took almost 90 minutes.

Sparring over lethal injection will resume in courts and legislatures this year as authorities grapple with tough questions about how much pain the condemned feel as they die and what role, if any, medical professionals should play in executions.

The battle over lethal injection is the latest strand in a long-running debate over the ultimate punishment. The United States is among a handful of industrialized countries that sanction capital punishment. China, a totalitarian state, remains the leader, executing thousands of prisoners annually.

Read the full analysis Lethal Injection on Trial, Already on Hold in 12 States, the Death Penalty Faces Further Attacks in Courts and Legislatures this Year on the Pew Research Center Web site.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up

MORE FROM PEW

A worker in a seafood market dumps bright orange shrimp from a blue bin onto a bed of ice between a lot of other seafood laid out for sale. Other workers are visible in the background, as are the arms of shoppers placing orders from the other side of the ice bed. Seafood Industry Benefits From Greater Vessel Transparency
An aerial view of a vast wetland, with scattered vegetation visible on sandy islands. In Western Australia, a Conservation Model for the World
A presentation being given by a businesswoman to a group of participants at a business conference. Four Plan Features Can Boost 'Retirement Readiness'
A large group of people in formal or traditional attire stands together on a stage, with a digital background depicting marine life and the large text “WTO Agreement on Fisheries Subsidies.” WTO Needs to Redouble Its Effort on Fishing Subsidies
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics
Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.
Quick View
Pills illustration

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.